VivoSim Labs, INC. entered into Securities Purchase Agreement with certain accredited investors (effective 2026-03-31).
“In connection with the Offering, the Company entered into a Securities Purchase Agreement (the “Purchase Agreement”) on March 31, 2026, the form of which is filed as Exhibit 10.1, and which contains customary representations and warranties and agreements of each party thereto and customary indemnification rights and oblig”
Vaidehi Joshi resigned as Director at VivoSim Labs, INC..
“On March 21, 2025, Vaidehi Joshi notified the Board of Directors (the "Board") of the Company that she resigned from the Board and all committees of the Board, effective as of March 21, 2025.”
Listing & Compliance Notices
VivoSim Labs, INC. received a nasdaq delisting notice notice regarding minimum bid price (rules 5550(a)(2)).
“January 16, 2025, the Staff provided a notice to the Company (the “Nasdaq Notice”) that the Company had not regained compliance with Rule 5550(a)(2) and is not eligible for a second 180 calendar day compliance period as”
Material Agreements
VivoSim Labs, INC. entered into Securities Purchase Agreements with certain purchasers valued at Public offering of 1,562,500 shares of common stock and accompanying Common Warrants at $0.80 per un (effective 2024-05-08).
“In connection with the Offering, the Company entered into Securities Purchase Agreements (the “Purchase Agreements”) with certain purchasers on May 8, 2024.”
Material Agreements
VivoSim Labs, INC. entered into Placement Agency Agreement with JonesTrading Institutional Services LLC valued at Cash fee of 5.0% of aggregate gross proceeds raised in the Offering; net proceeds approximately $4.7 (effective 2024-05-08).
“In connection with the Offering, the Company entered into a Placement Agency Agreement (the “Placement Agency Agreement”) on May 8, 2024 with JonesTrading Institutional Services LLC (the “Placement Agent”), as the placement agent in connection with the Offering.”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.